Results 191 to 200 of about 72,581 (277)

Recommendations to Improve Healthcare Service Provision for Cognitive Impairment in People With Parkinson's Disease: A Mixed Methods Study of the Lived Experience Expert Perspective

Health Expectations, Volume 29, Issue 2, April 2026.
ABSTRACT Background Cognitive impairment, including dementia, is one of the most important nonmotor symptoms of Parkinson's disease (PD). It lowers quality of life and impacts health and economic outcomes for individuals living with PD, their families, and society.
Deepa Sriram, Dana Pourzinal, Daniel X. Bailey, Deborah Brooks, Kirstine Shrubsole, Jihyun Yang, Neil Page, Emily McCann, Elton H. Lobo, James M. King, Leander K. Mitchell, Nancy A. Pachana, Nadeeka N. Dissanayaka   +12 more
wiley   +1 more source

Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline. [PDF]

Ann Neurol
Wood Alexander M, Fischer DL, VandeVrede L, Nichols E, Yu L, Pike JR, Swardfager W, Wu CY, Masellis M, Galea LAM, Zukotynski K, Einstein G, Black SE, Barnes LL, Schneider JA, Arvanitakis Z, Casaletto KB, Rabin JS.   +17 more
europepmc   +1 more source

The Association Between Caregiver Psychosocial Factors and Depressive Symptoms in People With Dementia: A Systematic Review and Meta‐Analysis

Journal of Advanced Nursing, Volume 82, Issue 4, Page 3906-3942, April 2026.
ABSTRACT Aims To identify and evaluate the magnitude of the association between caregiver psychosocial factors and depressive symptoms among people with dementia. Design Systematic review and meta‐analysis. Methods A systematic review with meta‐analysis used a random‐effects model to estimate the effect size.
Wenjing Ning, Shanshan Wang, Yudi Xu, Daphne Cheung   +3 more
wiley   +1 more source

RETRACTION: α-Synuclein Conformational Antibodies Fused to Penetratin are Effective in Models of Lewy Body Disease. [PDF]

Ann Clin Transl Neurol
europepmc   +1 more source

Minor Visual Phenomena in Lewy Body Disease: A Systematic Review. [PDF]

Biomedicines
Capogna E, Pollarini V, Quinzi A, Guidi L, Sambati L, Criante MS, Mengoli E, Venneri A, Lodi R, Tonon C, Mitolo M.   +10 more
europepmc   +1 more source

The Effect of Deep Brain Stimulation on Sleep and Cognition in Patients With Parkinson's Disease

Journal of Sleep Research, Volume 35, Issue 2, April 2026.
ABSTRACT Sleep–wake disturbances and cognitive decline are among the most common nonmotor symptoms of Parkinson's disease (PD). Deep brain stimulation (DBS) can successfully alleviate motor symptoms. However, the impact on sleep–wake disturbances and cognitive decline, and their interaction, is yet unclear.
Monique E. H. Valk‐Geuke, Gert J. Geurtsen, Rob M. A. de Bie, Rick Schuurman, Martijn Beudel, Esmée Verwijk   +5 more
wiley   +1 more source

Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer's and Lewy body disease. [PDF]

Brain
Duong MT, Das SR, Khandelwal P, Lyu X, Xie L, McGrew E, Dehghani N, McMillan CT, Lee EB, Shaw LM, Yushkevich PA, Wolk DA, Nasrallah IM.   +12 more
europepmc   +1 more source

An Autopsy Case With Fragile X‐Associated Tremor/Ataxia Syndrome Presenting Intranuclear Inclusion Bodies Mainly in the Limbic System

Neuropathology, Volume 46, Issue 2, April 2026.
ABSTRACT Fragile X‐associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder characterized by a late onset and slow progression caused by a premutation (55–200 CGG repeat) in the fragile X mental retardation (FMR1) gene. Here, we report the case of a Japanese patient with FXTAS which is the first case autopsied in Japan. The patient was
Ayako Shioya, Kazuhiro Ishii, Taiki Sato, Masayuki Noguchi, Akira Tamaoka, Yuko Saito   +5 more
wiley   +1 more source

Late-Onset Oral Cenesthopathy With Dopaminergic Dysfunction: Therapeutic Response to Pramipexole in a Case With Suspected Prodromal Lewy Body Disease. [PDF]

Psychogeriatrics
Matsui H, Tamura T, Kameyama M, Omori Y, Sugihara G, Takeuchi T, Takahashi H, Furuta K.   +7 more
europepmc   +1 more source

Recent Insights Into Alzheimer's Disease: Advances in Pathophysiology and Therapeutic Strategies

Brain Health, Volume 1, Issue 1, 26 March 2026.
ABSTRACT Alzheimer's disease (AD) is a complex neurodegenerative disorder driven by interplay among amyloid‐β (Aβ) plaques, tau neurofibrillary tangles, inflammation and comorbid pathologies. Recent advances in biomarkers and therapeutic approvals have reshaped our understanding of its pathophysiology and treatment landscape.
Jiong Shi, Jeffery Cummings, Jacques Touchon, Bruno Vellas   +3 more
wiley   +1 more source